九强生物：第五届监事会第十三次会议决议公告

Group 1 - The core point of the article is that Jiukang Bio announced the approval of the mid-term profit distribution plan for 2025 during its 13th meeting of the fifth supervisory board [2] Group 2 - The announcement was made on the evening of August 26, indicating the company's ongoing commitment to shareholder returns [2] - The specific details of the profit distribution plan were not disclosed in the announcement [2]